Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 1,002.05
+22.00 (2.24%)
Aug 21, 2026, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 50.82 billion as of August 21, 2026. Its market cap has increased by 32.24% in one year.
Market Cap
50.82B
Enterprise Value
53.62B
Revenue
8.52B
Ranking
n/a
PE Ratio
172.37
Stock Price
1,002.05
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 50.82B, an increase of 6,887.45%. That is a compound annual growth rate of 107.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 50.82B | 32.03% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 115.27B |
| Strides Pharma Science | 91.53B |
| Aarti Pharmalabs | 75.18B |
| Sun Pharma Advanced Research Company | 64.77B |
| Innova Captab | 62.04B |
| RPG Life Sciences | 43.91B |
| Solara Active Pharma Sciences | 30.83B |
| Ind-Swift Laboratories | 29.00B |